CRA was retained by a Fortune 100 pharmaceutical company to assess the multi-year selection process associated with a recent acquisition. Working with the client CRA developed analyses to examine the impact decisions commonly associated with blending companies. The analyses incorporated different selection processes for areas of overlap, merger required spin-offs, as well as general workforce adjustments. CRA’s analyses provided a “real-time” review of the decisions as they were being made to address particular areas of risk.
Is the EEOC pay data dashboard a cost-effective and useful way to evaluate pay equity issues?
The EEOC released dashboard information on pay collected in 2017 and 2018 in EEO-1 Component 2 submissions with a stated purpose of allowing companies to...